Summary of Significant Accounting Policies (Tables)

6 Months Ended

Dec. 31, 2024

Accounting Policies [Abstract]

Schedule of Net Revenue Disaggregated by Product and Region

The following table summarizes our net revenue disaggregated by segment, product and region (in thousands):

	Three Months Ended December 31,				Six Months Ended December 31,
	2024		2023		2024		2023
U.S., Canada and Latin America
Devices	$	414,453	$	371,336	$	798,983	$	717,233
Masks and other	334,496		297,994		657,271		590,455
Total U.S., Canada and Latin America	$	748,949	$	669,330	$	1,456,254	$	1,307,688
Combined Europe, Asia and other markets
Devices	$	254,849	$	234,661	$	496,104	$	453,492
Masks and other	121,795		113,864		240,972		219,712
Total Combined Europe, Asia and other markets	$	376,644	$	348,525	$	737,076	$	673,204
Global revenue
Total Devices	$	669,302	$	605,997	$	1,295,087	$	1,170,725
Total Masks and other	456,291		411,858		898,243		810,167
Total Sleep and Breathing Health	$	1,125,593	$	1,017,855	$	2,193,330	$	1,980,892
Residential Care Software	156,496		144,946		313,268		284,230
Total	$	1,282,089	$	1,162,801	$	2,506,598	$	2,265,122

Schedule of Contract Balances

The following table summarizes our contract balances (in thousands):

	December 31, 2024		June 30, 2024		Balance sheet caption
Contract assets
Accounts receivable, net	$	859,937	$	837,275	Accounts receivable, net
Unbilled revenue, current	$	47,019	$	38,183	Prepaid expenses and other current assets
Unbilled revenue, non-current	$	15,042	$	18,450	Prepaid taxes and other non-current assets
Contract liabilities
Deferred revenue, current	$	(156,508)	$	(152,554)	Deferred revenue (current liabilities)
Deferred revenue, non-current	$	(146,512)	$	(137,343)	Deferred revenue (non-current liabilities)